注射用雙黃連類過敏反應及其機制研究
本文關鍵詞:注射用雙黃連類過敏反應及其機制研究,由筆耕文化傳播整理發(fā)布。
similar.RepetitivedosingofSHLIdemonstratedsimilareffect、析tllhistamine.
3.2EffectofDiphenhydramineandSHLI
on
hypotensiveresponsesinducedbyhistamine
When
ratswereadministered、麗tllhistamine
at0.1
mg/kg
twicewith
Diphenhydraminegivenbeforethesecondhistamineinjection,themeanchangesof
MAPfrombaseline
tonadirwere69.1
mmHgand15.3mmHgaftereachhistamine
administrationrespectively(p<0.01).
When
ratswereadministered、析tllSHLIat0.1
mg/kg
twice、Ⅳitll
DiphenhydraminegivenbeforethesecondSHLIinjection,themeanchangesofMAPfrombaselinetonadirwere60.3administrationrespectively(p<0.01).
3.3EffectofCromolynandSHLI
on
mmHgand38.1
mmHg
aftereachSHLI
hypotensiveresponsesinducedbyCompound48/80
WhenCompound
48/80was
used,MAPdecreasedsignificantlyfrom
162.8-4-12.448/80was
mmHgtothenadirof104.54-12.0
mmHg(網(wǎng).003).WhenCompound
givenaftertheinfusionofCromolyn,theMAPdidnotchange.
When
attenuate
SHLI(200mg/kg)Wasinjected,MAPdecreasedrapidlyfrom156.74-4.6
mmHgto81.44-6.9mmHgp<o.00005).Pretreatment晰mCromolyncould
not
thehypotensiveresponsesinducedbySHLI,77.64-4.6mmHgVS.baseline
163.44-4.6mmHgp<o.0002)
on
3.4Effectofinfusionspeedhypotensiveresponsesinducedby
SHLI
SHLI(400
mg/kg,4.0
mE)Wasinfusedto
ratsat
thespeedof0.8,0.4
or
0.2
mL/min.TheresultsshowedthatthemaximummagnitudeofdecreaseinMAP
increased謝t11
、^rimthatdecreased
infusionspeed,andtheinitiationandendingofhypotensionconsisted
hypotensionWas
observedwhenthe
infusionspeed
ofinfusion.No
to0.2
mI,/min.
4Hypotensivematerialsdetection
8
SHLlwasobservedtoinducehypotensiveresponsesat2.8mg/kgincatsbyusingthehypotensivematerialsdetectionmethoddescribedintheChinese
In
Pharmacopoeia.
include
conclusion,thehypersensitivereactionsinduced
by
SHLImay
anaphylactoidreactionsprimarily.ThemechanismispossibletobemediatorsreleasefrommastcellsstimulatedbySHLI,whichleadstotoxicalsignsofmultiplesystems,
hypotentionforinstance.Histaminesimilarmaterialsmaybe
containedinSHLI,
possibletocontributetothehypertensivematerials
hypotension.Witllthemerits
act
ofsensitivityandrapidity,
test
detectionmayas
a
standardfordetectionof
anaphylactoidreactionsinducedbySHLI.It
isrecommendedthatthe
safety
evaluationofSHLIshouldincludehypertensivematerialsdetection.
Keywords:ShuanghuanglianforInjecting;Anaphylactoidreaction;Histamine;
Tryptase;Bloodpressure
9
英文縮寫D溺
ADR
HSIb
BN
AHR
IgE
MCI沖CM
IL.8
ICAM.1
CARPA
RCM
CrEL
TCC
C5b-9,MAC
SHLI
ELASA
10
山東大學碩士學位論文
符號說明
英文全稱
Ovalbumin
Adversedrugreaction
Hypersensitivityreactions
BrownNorway
Acute
hypersensitivereaction,
anaphylaxis
ImmunoglobulinE
Mast
cell
Ratperitonealmastcell
Interleukin.8
Intercellularadhesivemolecule.1
Complymentactivation-related
pseudoallergy
Radiocontrastmedia
CremophorELTerminalCcomplex
Membrane
attackcomplex
ShuanghuanglianforInjecting
Enzyme-linkedimmunoassay
中文全稱卵白蛋白藥物不良反應過敏反應棕色挪威
急性過敏反應
免疫球蛋白E肥大細胞
大鼠腹腔肥大細胞白細胞介素.8細胞間黏附分子.1
補體激活相關類過敏反應
放射對比造影劑聚氧乙烯蓖麻油終端補體復合物膜攻擊復合物注射用雙黃連酶聯(lián)免疫分析
山東大學碩士學位論文
OD
Opticaldensity
HCO.60
Hydrogenatedcastoroil60
CPIFab
CrotalidaepolyvalentimmuneFab
EDTA
EthylenediaminetetraaceticacideCGA
C11lomgemcacid
ⅣL心
Meanarterial
pressure
光密度氫化蓖麻油60響尾蛇多價免疫Fab乙二胺四乙酸綠原酸平均動脈壓
原創(chuàng)性聲明
本人鄭重聲明:所呈交的學位論文,是本人在導師的指導下,獨立進行研究所取得的成果。除文中已經(jīng)注明引用的內(nèi)容外,本論文不包含任何其他個人或集體已經(jīng)發(fā)表或撰寫過的科研成果。對本文的研究作出重要貢獻的個人和集體,均已在文中以明確方式標明。本聲明的法律責任由本人承擔。
論文作者簽名:
查墾董
日期:
關于學位論文使用授權的聲明
本人同意學校保留或向國家有關部門或機構送交論文的印刷件和電子版,,允許論文被查閱和借閱;本人授權山東大學可以將本學位論文的全部或部分內(nèi)容編入有關數(shù)據(jù)庫進行檢索,可以采用影印、縮印或其他復制手段保存論文和匯編本學位論文。
(保密論文在解密后應遵守此規(guī)定)
論文作者簽名:縋薹
導師簽
期:
本文關鍵詞:注射用雙黃連類過敏反應及其機制研究,由筆耕文化傳播整理發(fā)布。
本文編號:213482
本文鏈接:http://sikaile.net/yixuelunwen/yxlw/213482.html